SCHEMBL4848751

SCHEMBL4848751

c1ccc2c(c1)Cc1ccc3c4c(ccc3c1-2)Cc1ccccc1-4

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.50
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
KDM4E B2RXH2 2/20 0.47
MAPT P10636 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
HPGD P15428 1/20 0.47
BCHE P06276 1/20 0.41
CES1 P23141 1/20 0.41
SRD5A2 P31213 1/20 0.41
HTR2B P41595 2/20 0.41
POLB P06746 1/20 0.41
PLK4 O00444 1/20 0.39
DAPK3 O43293 1/20 0.39
PIM1 P11309 1/20 0.39
PDGFRA P16234 1/20 0.39
LTK P29376 1/20 0.39
MAP2K2 P36507 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30403300 0.87 MAOA (0.56) MAOANPC1RAB9AKDM4EMAPT
SCHEMBL4847777 0.87 HPRT1 (0.50) MAOANPC1RAB9AKDM4EMAPT
SCHEMBL21703801 0.85 PNMT (0.41) MAOANPC1RAB9AKDM4EMAPT
SCHEMBL29520144 0.83 DNMT1 (0.44) MAOANPC1RAB9AKDM4EMAPT
SCHEMBL867598 0.83 DNMT1 (0.44) MAOANPC1RAB9AKDM4EMAPT
SCHEMBL4848717 0.83 MAOA (0.43) MAOANPC1RAB9AKDM4EMAPT
SCHEMBL13562191 0.80 ACHE (0.44) MAOANPC1RAB9AKDM4EMAPT
SCHEMBL13562177 0.80 NPC1 (0.37) MAOANPC1RAB9AKDM4EMAPT
SCHEMBL815143 0.80 MAOA (0.34) MAOANPC1RAB9AKDM4EMAPT
SCHEMBL13562173 0.80 TDP1 (0.40) MAOANPC1RAB9AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9876182-B2 Thieno-containing compounds and processes and uses thereof UNIVERSITY OF OREGON (US) 2018-01-23 US disclosed
US-20160164011-A1 THIENO-CONTAINING COMPOUNDS AND PROCESSES AND USES THEREOF UNIVERSITY OF OREGON (US) 2016-06-09 US disclosed
US-7470290-B2 Hydroscopic polymer gels for easier cleaning THE CLOROX COMPANY (US) 2008-12-30 US disclosed
US-7183010-B2 Organic light-emitting diode devices with improved operational stability EASTMAN KODAK CORPORATION (US) 2007-02-27 US disclosed
US-20050245428-A1 Hydroscopic polymer gels for easier cleaning RODRIGUES KLIN A 2005-11-03 US disclosed
US-20040076853-A1 Organic light-emitting diode devices with improved operational stability EASTMAN KODAK COMPANY 2004-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160164011-A1 THIENO-CONTAINING COMPOUNDS AND PROCESSES AND USES THEREOF TERT, TES, DDT MAOA 375/4885NPC1 4803/4885RAB9A 3765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.